Tag Archives: announcement

RESI Panel Announcement: Healthcare System Partners

31 Mar

By Shaoyu Chang, MD, MPH, Senior Research Manager, LSN

Shaoyu 10*10

The RESI team is pleased to debut a new panel on Healthcare System Partners at RESI@TMCx on April 11. In an article titled “Innovation as Discipline, Not Fad,” the New England Journal of Medicine called on healthcare organizations to embrace innovations and serve as the training ground to test their medical benefits, technical feasibility, and business viability. Many healthcare systems are doing just that. This panel will reveal the changing role healthcare organizations are playing in fostering innovation.

Moderated by Rebecca Kaul, Chief Innovation Officer, MD Anderson, this session will feature:

From innovation centers to investment vehicles, healthcare organizations have become critical partners for entrepreneurs. Whether you are considering generating user experience, conducting pilot studies, or receiving technical guidance, the value of face-to-face meetings with these institutions is unfathomable. At the heart of the world’s largest medical center, this panel will help entrepreneurs navigate complex healthcare systems and bring their companies to the next milestone.

Registering for the RESI Conference will give you the opportunity to listen to this panel live, connect with relevant investors and network with like-minded entrepreneurs.

RESI-Houston-2016_600

Tags: , , , , , ,

RESI@TMCx Panel Announcement: Diagnostic Investors

24 Mar

By Cole Bunn, Research Analyst, LSN

cole-wp

The diagnostics space encompasses a very wide range of technologies targeting indications across the board, and is arguably the most difficult sector, under the life science umbrella, to successfully navigate. Not only do these entrepreneurs have to first identify the correct capital providers and strategic partners to make their technologies a commercial reality, like everyone else, but piquing the interests of those entities may be considerably more difficult. Oftentimes, clearly articulating the value proposition of your diagnostic product/service is a little trickier than that of a more traditional therapeutic or medical device, and the go-to-market strategy for these technologies will usually be more highly scrutinized.

Moderated by John Walter, CEO & President, Alliance for Cancer Gene Therapy Foundation, this session will feature:

Given the complex strategic landscape diagnostics often face, along with the importance of the having the correct strategy in place, the value of guidance and feedback from experienced diagnostic investors can’t be overstated. This diverse set of panelists, representing a variety of different funds and organizations, will give the audience firsthand perspectives to help position their companies for success.

Registering for the RESI Conference will give you the opportunity to listen to this panel live, connect with relevant investors and network with like-minded entrepreneurs.

Tags: , , , , , , ,

RESI@TMCx Innovation Challenge: Participating Startups Announced

17 Mar

By Shaoyu Chang, MD, MPH, Senior Research Manager, LSN

Shaoyu 10*10

It’s time to announce the successful applicants to the RESI@TMCx Innovation Challenge. LSN’s scientific review board have assessed and ranked all entrants across a wide range of criteria, from scientific novelty to strength of IP, to select the 30 strongest entrants. These entrepreneurs will receive a presentation space in the RESI@TMCx exhibit hall for the full day of the conference to showcase their innovations to investors and fellow entrepreneurs. All RESI attendees have the opportunity to vote in the Innovation Challenge by “investing” in the best of these companies.

If your company missed this opportunity to compete in the RESI@TMCx Innovation Challenge, you can now enter the RESI on MaRS Innovation Challenge, to be held on June 23rd in Toronto.

 

Tags: , , , , ,

RESI@TMCx Panel Announcement: Incubators, Accelerators & New Models

17 Mar

By Lucy Parkinson, Director of Research, LSN

With the explosion of activity in early stage life sciences in the last few years, many new programs have been formed to support the youngest new biotech, medtech and healthcare IT companies in developing their products and making first steps toward commercialization.

This RESI panel will highlight five programs that provide vital resources at the earliest stage, including support, work space, mentoring, business education, and investment. The panelists will talk about how they select companies, how they help entrepreneurs turn scientific ideas into commercial success stories, and what makes each of their programs unique.

Moderated by Atul Varadhachary, Managing Partner, Fannin Innovation Studio, this session will feature:

Tags: , , , , , ,

RESI@TMCx Panel Announcement: Early Stage Therapeutic Investors

10 Mar

By Lucy Parkinson, Director of Research, LSN

Early stage therapeutics companies have a long road ahead to reach the marketplace, and will require significant investment along their way. The level of risk involved at this stage deters some investors, and much has been written about the pull-back of many venture capital firms from this phase of investment. At RESI, a panel of 5 investors who are highly experienced in investing in early stage therapeutic development will discuss how they pick winning scientfic teams and support their portfolio companies through the challenges of the development process.

Moderated by Lisa Rhoads, Managing Director, Easton Capital, the panel will feature:

This panel will give fundraising entrepreneurs a firsthand look at the strategies used by early stage therapeutic investors to assess companies at the earliest, riskiest stage of development, and will help the audience to position their companies as an attractive investment opportunity.

By registering for RESI@TMCx, you’ll be able to listen to the early stage therapeutic panel live in person, and also experience numerous opportunities to expand your network in the life sciences and to learn more about the fundraising process.

RESI-Houston-2016_600

Tags: , , , , , , , ,

RESI@TMCx Panel Announcement: Venture Philanthropy Investors

10 Mar

By Christine A. Wu, Research Analyst, LSN

chrsitine

Venture philanthropy organizations provide more than just financing. Often times, these investors can provide a network of experts, patients, and resources in their niche space. Here in Next Phase, LSN has previously covered trends in venture philanthropy investment and advice in how to approach venture philanthropy investors.

LSN is pleased to announce a panel of five investors in the venture philanthropy space for RESI@TMCx on April 11th. Moderated by Jit Patel, VP of Research and Business Development of Juvenile Diabetes Research Foundation (JDRF), the panel will be joined by:

Panelists will address their specific investment criteria and unique missions; their investment decision-making process; important trends in the space; and the best approach to reach and heighten their interest.

Interested in this panel? It’s not too late to register for RESI@TMCx Houston and see this panel live. View the full RESI@TMCx agenda here. You can also view a video recap of our RESI San Francisco Venture Philanthropy session.

RESI-Houston-2016_600

Tags: , , , , , ,

RESI@TMCx: Agenda Announced

11 Feb

By Nono Hu, Director of Marketing, LSN

RESI is returning to TMCx on April 11th, and LSN has scheduled two all-day tracks of panel sessions that illuminate every corner of the life science investment landscape. Panels will feature senior, experienced investors from a diversity of investor types – including family offices, VCs, angel syndicates, major global pharma and medical device firms, and more. These investors will explore new investment trends in their sectors, and will share their knowledge and insights with RESI’s audience of entrepreneurs. If you’d like to join us at RESI@TMCx to hear the latest on life science financing and book one-on-one meetings with investors, you can register here.

Tags: , , ,

← Older Entries
Newer Entries →